The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.00
Bid: 308.00
Ask: 308.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.162%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 306.00
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of New Chair

17 Dec 2020 07:00

RNS Number : 9240I
Synthomer PLC
17 December 2020
 

17th December 2020

 

Synthomer plc ('Synthomer' or 'the Company')

 

Appointment of New Chair

 

Synthomer announces that on 16th December Neil Johnson stepped down as Chairman of the Company after nine years on the Board, eight of which have been as Chair.

 

As announced on 30th March 2020, the Board is pleased to confirm that Caroline Johnstone has succeeded Neil as Chair of Synthomer. Caroline joined the Board as a non-executive director in 2015, where she has been Chair of the Audit Committee and a member of the Nomination and Remuneration Committees. Cynthia Dubin will replace Caroline as Chair of the Audit Committee.

 

Caroline has nearly 40 years' experience of working with chemicals and other large global organisations. Her experience includes delivering value from mergers and acquisitions, culture change and cost optimisation. She was a partner in PricewaterhouseCoopers (PwC) and sat on the Board of its UK Assurance practice, with responsibility for all people matters. Caroline is a chartered accountant and a member of the Institute of Chartered Accountants of Scotland. She is a non-executive director of Spirax Sarco Engineering plc and Shepherd Building Group Limited, a private company which owns the Portakabin business. She also has an honorary position on the governing board of the University of Manchester. 

 

Neil Johnson commented:

 

"It has been a pleasure serving on Synthomer's Board for the last nine years. During that time, the Company has successfully established itself as a leading, global, differentiated chemicals business. As confirmed in our recent Q3 trading update, Synthomer is benefiting from its clear strategy and effective business model and has proven resilient during the COVID-19 pandemic, with trading momentum across all divisions. Synthomer is well placed for the future, not least as it realises the benefits of the OMNOVA acquisition completed earlier this year.

 

I am delighted that I will be succeeded by Caroline, who has made a significant contribution to the Company during her time on the Board and who will preside over a business that I know can go from strength to strength." 

 

Caroline Johnstone commented:

 

"On behalf of the Board, I would like to thank Neil for the enormous contribution that he has made to the business over the last nine years. He has overseen a huge period of change and progress, and he leaves with our best wishes for the future. It is a privilege to succeed him as Chair and I look forward to working with other Board colleagues and the management team to take the business forward."

 

Enquiries:

 

Synthomer plc

Tel: + 44 7764 859147

Tim Hughes, President, Corporate Development

 

 

 

Teneo

Tel: + 44 7703 330 269

Charles Armitstead / Matt Denham

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZMMZRVDGGZM
Date   Source Headline
5th Aug 20221:20 pmRNSHolding(s) in Company
5th Aug 202211:27 amRNSDirector/PDMR Shareholding
4th Aug 20222:57 pmRNSDirector/PDMR Shareholding
4th Aug 20222:35 pmRNSDirector/PDMR Shareholding
3rd Aug 202212:29 pmRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSResults for the six months ended 30 June 2022
15th Jul 20222:32 pmRNSHolding(s) in Company
8th Jul 202210:23 amRNSHolding(s) in Company
1st Jul 20227:00 amRNSChief Financial Officer
30th Jun 20225:04 pmRNSHolding(s) in Company
21st Jun 20227:00 amRNSAppointment of Non-Executive Director
17th May 202212:55 pmRNSHolding(s) in Company
5th May 202212:39 pmRNSHolding(s) in Company
4th May 20224:46 pmRNSDirector/PDMR Shareholding
4th May 20227:00 amRNSAppointment of Joint Corporate Brokers
28th Apr 202212:24 pmRNSResult of AGM
28th Apr 20227:00 amRNSQ1 2022 trading update
26th Apr 20229:33 amRNSHolding(s) in Company
20th Apr 20224:13 pmRNSHolding(s) in Company
5th Apr 20224:18 pmRNSDirector/PDMR Shareholding
1st Apr 20221:34 pmRNSCompletion of adhesives acquisition
29th Mar 20223:17 pmRNSHolding(s) in Company
29th Mar 20223:14 pmRNSDirector/PDMR Shareholding
25th Mar 20222:03 pmRNSAnnual Financial Report
14th Mar 202212:50 pmRNSDirector/PDMR Shareholding
14th Mar 202212:50 pmRNSDirector/PDMR Shareholding
14th Mar 202212:48 pmRNSDirector/PDMR Shareholding
14th Mar 20229:35 amRNSHolding(s) in Company
9th Mar 202212:52 pmRNSDirector/PDMR Shareholding
8th Mar 20223:22 pmRNSDirector/PDMR Shareholding
8th Mar 20223:19 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSPreliminary Results for the year ended 31 Dec 2021
14th Feb 20227:00 amRNSPre-close trading update
10th Feb 20223:10 pmRNSNOTIFICATION OF MAJOR HOLDINGS
22nd Dec 20215:10 pmRNSDirector/PDMR Shareholding
21st Dec 20213:09 pmRNSDirector/PDMR Shareholding
20th Dec 20213:40 pmRNSDirector/PDMR Shareholding
17th Dec 202112:29 pmRNSResults of General Meeting
15th Dec 20212:54 pmRNSDirector/PDMR Shareholding
30th Nov 20214:57 pmRNSPUBLICATION OF CIRCULAR
26th Nov 20217:00 amRNSAppointment of Chief Financial Officer
22nd Nov 202110:36 amRNSDirector Declaration
11th Nov 20212:24 pmRNSDirector/PDMR Shareholding
4th Nov 20212:11 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSNew Chief Executive
28th Oct 20213:17 pmRNSResult of Placing
28th Oct 20217:00 amRNSAcquisition
28th Oct 20217:00 amRNSPROPOSED PLACING OF NEW ORDINARY SHARES
30th Sep 20213:08 pmRNSDirectorate Change
10th Sep 20218:23 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.